CEFTOZEN 4.5

CEFTOZEN 4.5

Composition:

• Each vial contains:
• Ceftriaxone Sodium IP (Sterile) eq. to
• Anhydrous Ceftriaxone …………… 4000 mg
• Tazobactam Sodium IP (Sterile) eq. to
• Tazobactam …………………….. 500 mg

Benefits:

• Broad-spectrum antibacterial activity against G+ve & G-ve pathogens
• Effective against ß-lactamase–producing resistant bacteria including ESBLs
• Effective against E. coli, Salmonella & resistant pathogens
• Extended 8-hour half-life supports convenient once-daily dosing
• Low MIC against pathogens
• No nephrotoxicity concerns; primarily excreted unchanged via the kidneys

Indications:

• Colibacillosis (E. coli)
• Salmonella (Pullorum Disease, Fowl Typhoid)
• Pasteurella (Fowl Cholera)
• Infectious Coryza
• Omphalitis (Yolk Sac Infection)
• CCRD and other mixed bacterial infections

Administration:

• 15-25mg of Ceftriaxone per kg BW or advised by veterinarian Caution: In vitro studies have shown possible antagonism when chloramphenicol is used concurrently with ceftriaxone.

Presentation:

• 4500mg